New Model of Integrated Care of Older Patients With Atrial Fibrillation in Rural China
-
- STATUS
- Recruiting
-
- End date
- Nov 30, 2023
-
- participants needed
- 1000
-
- sponsor
- The First Affiliated Hospital with Nanjing Medical University
Summary
This cluster randomization study aims to compare the people-centered integrated care versus usual care to improve outcome of older patients with atrial fibrillation in rural China.
Description
BACKGROUND Atrial fibrillationAFprevalence increases sharply with age, and the risk of stroke, dementia, heart failure and death increases significantly. Epidemiological data show that the risk of atrial fibrillation-associated ischemic stroke in Asian population is higher than that in western population, but the use of oral anticoagulant is significantly lower than that in western population. However, elderly patients with atrial fibrillation often have a high risk of stroke and cerebral hemorrhage at the same time. How to balance the anticoagulant effect and bleeding risk is a challenge for rural doctors in rural China. Integrated care for atrial fibrillation patients using simple ABC pathway ('A' Avoid stroke; 'B' Better symptom management; 'C' Cardiovascular and Comorbidity optimization) is associated with a lower risk of adverse outcomes included all-cause death, composite outcome of stroke/major bleeding/cardiovascular death, and first hospitalization. However, the role of people-centered integrated care for AF patients in rural China has remained unclear.
AIM OF THIS STUDY This cluster randomization study aims to compare the people-centered integrated care versus usual care to improve outcome of older patients with atrial fibrillation in rural China. The primary endpoint is the composite of cardiovascular death and all stroke. The secondary endpoints are All-cause mortality, cardiovascular death, cardiovascular hospitalization, ischemic or hemorrhagic stroke, major bleeding, clinically relevant nonmajor bleeding, quality of life.
DESIGN The MIRACLE-AF China trial is a multicenter, perspective, cluster randomization clinical trial performed in rural China. We aim to include a minimum of 1000 patients with AF aged 65 years or above from around more than 30 village clinics. Follow-up duration of this study is up to 3 years and all patients are followed up every 3 months by rural doctors. Village clinics will be randomized to either the intervention group (people-centered integrated care) or the control group (usual care).
Details
| Condition | Arrhythmia, Dysrhythmia, Arrhythmia, Atrial Fibrillation, Atrial Fibrillation, Atrial Fibrillation (Pediatric), Cerebrovascular accident, Stroke, Atrial Fibrillation (Pediatric), Stroke, Dysrhythmia, cerebrovascular accidents, strokes, cerebral, Older |
|---|---|
| Treatment | Usual Care, People-centered integrated care |
| Clinical Study Identifier | NCT04622514 |
| Sponsor | The First Affiliated Hospital with Nanjing Medical University |
| Last Modified on | 26 January 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer